Michael Fralick

Faculty Member

Michael is a board-certified General Internist in Canada and the US. He completed his undergraduate degree at Queen’s University and his medical degree and internal medicine residency training at the University of Toronto. Thereafter, he completed a Master’s of Science in Clinical Epidemiology at Harvard University. His PhD, completed at the University of Toronto, focused on the intersection between supervised machine learning and pharmacoepidemiology. During the COVID-19 pandemic, he shifted his research focus to pragmatic clinical trials and was co-investigator on SOLIDARITY, RAPID COVID COAG, and CONCOR-1, and co-principal investigator for the COVID-PRONE clinical trial. Currently, Michael is Clinician Scientist at Sinai Health in Toronto and Assistant Professor at the University of Toronto’s Faculty of Medicine. He also works clinically at the Sault Area Hospital in Sault Ste. Marie, Ontario. He is on board of NEJM Evidence, a new journal part of the NEJM Family. He is also a budding gardener (pun intended), mediocre golfer, and seasoned barista.